REGN Regeneron Pharmaceuticals
Nasdaq · SEC CIK 872589 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $12.91M 15 sales by 7 insiders
- Filings on record
- 402 since 2021-07-02, latest 2026-09-03 16:50
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| POON CHRISTINE A | Dir | — | $4.25M |
| McCourt Marion | EVP Commercial | — | $2.00M |
| Zoghbi Huda Y | Dir | — | $1.92M |
| Pitofsky Jason | VP Ctrl | — | $1.87M |
| Bassler Bonnie L | Dir | — | $1.77M |
| Guarini Kathryn | Dir | — | $660.0K |
| RYAN ARTHUR F | Dir | — | $434.7K |
| MURPHY ANDREW J | EVP Research | — | — |
| Fenimore Christopher R. | EVP Fin CFO | — | — |
| Schenkein David P | Dir | — | — |
Transactions 678
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-02-05 | 2024-02-01 | REGN | RYAN ARTHUR F | Dir | S - Sale | $954.22 | -100 | 18.5K | -0.5% | -$95.4K |
| 2024-02-02 | 2024-02-01 | REGN | McCourt Marion | EVP Commercial | S - Sale | $945.61 | -273 | 14.8K | -2% | -$258.2K | |
| D | 2024-02-02 | 2024-01-31 | REGN | Landry Robert E | EVP Fin CFO | M - OptEx | $378.98 | +400 | 23.9K | +2% | +$151.6K |
| D | 2024-02-02 | 2024-01-31 | REGN | Landry Robert E | EVP Fin CFO | F - Tax | $953.42 | -282 | 23.6K | -1% | -$268.9K |
| D | 2024-01-31 | 2024-01-30 | REGN | Bassler Bonnie L | Dir | M - OptEx | $380.95 | +827 | 2,209 | +60% | +$315.0K |
| D | 2024-01-31 | 2024-01-30 | REGN | Bassler Bonnie L | Dir | S - Sale+OE | $959.00 | -827 | 1,382 | -37% | -$793.1K |
| DM | 2024-01-25 | 2024-01-23 | REGN | Fenimore Christopher R. | SVP Ctrl | M - OptEx | $477.67 | +10.0K | 22.9K | +78% | +$4.78M |
| DM | 2024-01-25 | 2024-01-23 | REGN | Fenimore Christopher R. | SVP Ctrl | F - Tax | $948.50 | -7,569 | 17.9K | -30% | -$7.18M |
| DM | 2024-01-25 | 2024-01-23+ | REGN | Landry Robert E | EVP Fin CFO | F - Tax | $949.36 | -1,128 | 23.5K | -5% | -$1.07M |
| DM | 2024-01-25 | 2024-01-23+ | REGN | Landry Robert E | EVP Fin CFO | M - OptEx | $378.98 | +1,600 | 24.1K | +7% | +$606.4K |
| D | 2024-01-25 | 2024-01-23 | REGN | GOLDSTEIN JOSEPH L | Dir | M - OptEx | $625.60 | +2,707 | 9,089 | +42% | +$1.69M |
| D | 2024-01-25 | 2024-01-23 | REGN | GOLDSTEIN JOSEPH L | Dir | S - Sale+OE | $950.00 | -2,707 | 6,382 | -30% | -$2.57M |
| D | 2024-01-18 | 2024-01-17 | REGN | Landry Robert E | EVP Fin CFO | F - Tax | $932.34 | -354 | 23.0K | -2% | -$330.0K |
| D | 2024-01-18 | 2024-01-17 | REGN | Landry Robert E | EVP Fin CFO | M - OptEx | $378.98 | +500 | 23.3K | +2% | +$189.5K |
| D | 2024-01-17 | 2024-01-12 | REGN | Landry Robert E | EVP Fin CFO | M - OptEx | $378.98 | +800 | 23.4K | +4% | +$303.2K |
| D | 2024-01-17 | 2024-01-12 | REGN | Landry Robert E | EVP Fin CFO | F - Tax | $928.18 | -568 | 22.8K | -2% | -$527.2K |
| D | 2024-01-08 | 2024-01-04 | REGN | Landry Robert E | EVP Fin CFO | F - Tax | $917.05 | -342 | 22.6K | -1% | -$313.6K |
| D | 2024-01-08 | 2024-01-04 | REGN | Landry Robert E | EVP Fin CFO | M - OptEx | $378.98 | +500 | 22.9K | +2% | +$189.5K |
| I | 2024-01-04 | 2024-01-02 | REGN | YANCOPOULOS GEORGE | Pres, CSO, Bd. Co-COB, Dir | S - Sale | $900.00 | -16.8K | 180.0K | -9% | -$15.16M |
| D | 2024-01-04 | 2024-01-02 | REGN | Guarini Kathryn | Dir | A - Grant | $0.00 | +42 | 282 | +18% | $0 |
| D | 2024-01-04 | 2024-01-03 | REGN | Bassler Bonnie L | Dir | S - Sale+OE | $914.00 | -826 | 1,382 | -37% | -$755.0K |
| D | 2024-01-04 | 2024-01-03 | REGN | Bassler Bonnie L | Dir | M - OptEx | $380.95 | +826 | 2,208 | +60% | +$314.7K |
| D | 2024-01-04 | 2024-01-02 | REGN | Bassler Bonnie L | Dir | A - Grant | $0.00 | +135 | 1,382 | +11% | $0 |
| DM | 2024-01-04 | 2024-01-02+ | REGN | Landry Robert E | EVP Fin CFO | M - OptEx | $378.98 | +1,750 | 23.1K | +8% | +$663.2K |
| DM | 2024-01-04 | 2024-01-02+ | REGN | Landry Robert E | EVP Fin CFO | F - Tax | $903.20 | -1,109 | 22.0K | -5% | -$1.00M |
| D | 2024-01-04 | 2024-01-02 | REGN | POON CHRISTINE A | Dir | A - Grant | $0.00 | +135 | 2,172 | +7% | $0 |
| 2024-01-04 | 2024-01-02 | REGN | McCourt Marion | EVP Commercial | S - Sale | $873.91 | -274 | 15.1K | -2% | -$239.5K | |
| D | 2024-01-04 | 2024-01-02 | REGN | Zoghbi Huda Y | Dir | M - OptEx | $391.92 | +1,117 | 2,364 | +90% | +$437.8K |
| D | 2024-01-04 | 2024-01-02 | REGN | Zoghbi Huda Y | Dir | S - Sale+OE | $900.00 | -1,117 | 1,247 | -47% | -$1.01M |
| D | 2024-01-04 | 2024-01-02 | REGN | Zoghbi Huda Y | Dir | A - Grant | $0.00 | +135 | 1,382 | +11% | $0 |
| D | 2024-01-04 | 2024-01-02 | REGN | SING GEORGE L | Dir | A - Grant | $0.00 | +135 | 26.3K | +0.5% | $0 |
| D | 2024-01-04 | 2024-01-02 | REGN | COLES N ANTHONY | Dir | A - Grant | $0.00 | +135 | 1,393 | +11% | $0 |
| D | 2024-01-04 | 2024-01-02 | REGN | Thompson Craig B. | Dir | A - Grant | $0.00 | +135 | 454 | +42% | $0 |
| D | 2024-01-04 | 2024-01-02 | REGN | BROWN MICHAEL S | Dir | A - Grant | $0.00 | +135 | 1,382 | +11% | $0 |
| D | 2024-01-04 | 2024-01-02 | REGN | GOLDSTEIN JOSEPH L | Dir | A - Grant | $0.00 | +135 | 6,382 | +2% | $0 |
| DM | 2024-01-04 | 2024-01-03 | REGN | Fenimore Christopher R. | SVP Ctrl | F - Tax | $912.30 | -7,512 | 15.3K | -33% | -$6.85M |
| DM | 2024-01-04 | 2024-01-03 | REGN | Fenimore Christopher R. | SVP Ctrl | M - OptEx | $477.67 | +10.0K | 19.4K | +107% | +$4.78M |
| D | 2024-01-04 | 2024-01-03 | REGN | LAROSA JOSEPH J | EVP GC, Secret | M - OptEx | $399.66 | +34.0K | 64.0K | +113% | +$13.59M |
| D | 2024-01-04 | 2024-01-03 | REGN | LAROSA JOSEPH J | EVP GC, Secret | F - Tax | $912.30 | -24.5K | 39.5K | -38% | -$22.34M |
| D | 2024-01-04 | 2024-01-02 | REGN | Schenkein David P | Dir | A - Grant | $0.00 | +42 | 282 | +18% | $0 |
| DM | 2024-01-04 | 2024-01-02 | REGN | RYAN ARTHUR F | Dir | S - Sale | $899.90 | -100 | 18.4K | -0.5% | -$90.0K |
| D | 2024-01-04 | 2024-01-02 | REGN | RYAN ARTHUR F | Dir | A - Grant | $0.00 | +135 | 18.5K | +0.7% | $0 |
| D | 2023-12-29 | 2023-12-27 | REGN | BROWN MICHAEL S | Dir | M - OptEx | $482.68 | +2,049 | 3,296 | +164% | +$989.0K |
| D | 2023-12-29 | 2023-12-27 | REGN | BROWN MICHAEL S | Dir | S - Sale+OE | $898.00 | -2,049 | 1,247 | -62% | -$1.84M |
| 2023-12-29 | 2023-12-27 | REGN | Fenimore Christopher R. | SVP Ctrl | S - Sale | $856.71 | -2,448 | 14.4K | -15% | -$2.10M | |
| DM | 2023-12-29 | 2023-12-27+ | REGN | Landry Robert E | EVP Fin CFO | M - OptEx | $378.98 | +1,600 | 22.4K | +8% | +$606.4K |
| DM | 2023-12-29 | 2023-12-27+ | REGN | Landry Robert E | EVP Fin CFO | F - Tax | $878.93 | -1,154 | 21.8K | -5% | -$1.01M |
| M | 2023-12-26 | 2023-12-21+ | REGN | Fenimore Christopher R. | SVP Ctrl | S - Sale | $844.30 | -1,930 | 16.8K | -10% | -$1.63M |
| 2023-12-14 | 2023-12-12 | REGN | McCourt Marion | EVP Commercial | F - Tax | $856.71 | -5,105 | 15.3K | -25% | -$4.37M | |
| 2023-12-14 | 2023-12-12 | REGN | Fenimore Christopher R. | SVP Ctrl | F - Tax | $856.71 | -2,552 | 18.8K | -12% | -$2.19M | |
| D | 2023-12-14 | 2023-12-13 | REGN | Bassler Bonnie L | Dir | M - OptEx | $376.69 | +610 | 1,857 | +49% | +$229.8K |
| D | 2023-12-14 | 2023-12-13 | REGN | Bassler Bonnie L | Dir | S - Sale+OE | $870.00 | -610 | 1,247 | -33% | -$530.7K |
| 2023-12-14 | 2023-12-12 | REGN | MURPHY ANDREW J | EVP Research | F - Tax | $856.71 | -7,657 | 48.3K | -14% | -$6.56M | |
| DM | 2023-12-14 | 2023-12-12+ | REGN | Landry Robert E | EVP Fin CFO | F - Tax | $858.18 | -7,104 | 21.1K | -25% | -$6.10M |
| D | 2023-12-14 | 2023-12-13 | REGN | Landry Robert E | EVP Fin CFO | M - OptEx | $378.98 | +1,000 | 22.1K | +5% | +$379.0K |
| D | 2023-12-13 | 2023-12-11 | REGN | YANCOPOULOS GEORGE | Pres, CSO, Bd. Co-COB, Dir | M - OptEx | — | +25.2K | 765.3K | +3% | — |
| D | 2023-12-13 | 2023-12-11 | REGN | YANCOPOULOS GEORGE | Pres, CSO, Bd. Co-COB, Dir | F - Tax | $844.09 | -12.8K | 752.5K | -2% | -$10.84M |
| D | 2023-12-13 | 2023-12-11 | REGN | SCHLEIFER LEONARD S | Pres, CEO, Bd. Co-COB, Dir | F - Tax | $844.09 | -12.8K | 374.4K | -3% | -$10.84M |
| D | 2023-12-13 | 2023-12-11 | REGN | SCHLEIFER LEONARD S | Pres, CEO, Bd. Co-COB, Dir | M - OptEx | — | +25.2K | 387.3K | +7% | — |
| M | 2023-12-12 | 2023-12-08+ | REGN | Landry Robert E | EVP Fin CFO | F - Tax | $844.02 | -4,234 | 30.0K | -12% | -$3.57M |
| DM | 2023-12-12 | 2023-12-08+ | REGN | LAROSA JOSEPH J | EVP GC, Secret | F - Tax | $843.92 | -1,521 | 30.0K | -5% | -$1.28M |
| D | 2023-12-12 | 2023-12-08 | REGN | LAROSA JOSEPH J | EVP GC, Secret | A - Grant | $0.00 | +2,133 | 30.7K | +7% | $0 |
| DM | 2023-12-12 | 2023-12-08+ | REGN | STAHL NEIL | EVP Research, Development | F - Tax | $843.93 | -1,534 | 52.0K | -3% | -$1.29M |
| D | 2023-12-12 | 2023-12-08 | REGN | STAHL NEIL | EVP Research, Development | A - Grant | $0.00 | +853 | 52.7K | +2% | $0 |
| D | 2023-12-12 | 2023-12-08 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | A - Grant | $0.00 | +3,199 | 23.6K | +16% | $0 |
| DM | 2023-12-12 | 2023-12-08+ | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | F - Tax | $844.01 | -4,329 | 20.4K | -18% | -$3.65M |
| D | 2023-12-12 | 2023-12-11 | REGN | McCourt Marion | EVP Commercial | S - Sale | $838.44 | -270 | 20.8K | -1% | -$226.4K |
| D | 2023-12-12 | 2023-12-08 | REGN | McCourt Marion | EVP Commercial | A - Grant | $0.00 | +2,133 | 21.1K | +11% | $0 |
| DM | 2023-12-12 | 2023-12-08+ | REGN | McCourt Marion | EVP Commercial | F - Tax | $843.88 | -1,225 | 20.4K | -6% | -$1.03M |
| DM | 2023-12-12 | 2023-12-08+ | REGN | MURPHY ANDREW J | EVP Research | F - Tax | $844.05 | -6,657 | 58.5K | -10% | -$5.62M |
| D | 2023-12-12 | 2023-12-08 | REGN | MURPHY ANDREW J | EVP Research | A - Grant | $0.00 | +3,199 | 61.7K | +5% | $0 |
| D | 2023-12-12 | 2023-12-08 | REGN | Fenimore Christopher R. | SVP Ctrl | A - Grant | $0.00 | +2,370 | 22.8K | +12% | $0 |
| DM | 2023-12-12 | 2023-12-08+ | REGN | Fenimore Christopher R. | SVP Ctrl | F - Tax | $844.02 | -2,010 | 21.3K | -9% | -$1.70M |
| DM | 2023-12-06 | 2023-12-05 | REGN | MURPHY ANDREW J | EVP Research | S - Sale+OE | $817.44 | -6,536 | 59.4K | -10% | -$5.34M |
| D | 2023-12-06 | 2023-12-04 | REGN | MURPHY ANDREW J | EVP Research | M - OptEx | $270.43 | +20.0K | 79.4K | +34% | +$5.41M |
| D | 2023-12-06 | 2023-12-04 | REGN | MURPHY ANDREW J | EVP Research | F - Tax | $813.58 | -13.5K | 66.0K | -17% | -$10.95M |
| M | 2023-12-04 | 2023-12-01 | REGN | RYAN ARTHUR F | Dir | S - Sale | $817.30 | -100 | 18.5K | -0.5% | -$81.7K |
| D | 2023-11-15 | 2023-11-13 | REGN | MURPHY ANDREW J | EVP Research | M - OptEx | $270.43 | +20.0K | 79.4K | +34% | +$5.41M |
| D | 2023-11-15 | 2023-11-13 | REGN | MURPHY ANDREW J | EVP Research | F - Tax | $795.69 | -13.5K | 65.9K | -17% | -$10.75M |
| DM | 2023-11-15 | 2023-11-14 | REGN | MURPHY ANDREW J | EVP Research | S - Sale+OE | $799.17 | -6,492 | 59.4K | -10% | -$5.19M |
| 2023-11-14 | 2023-11-10 | REGN | STAHL NEIL | EVP Research, Development | G - Gift | $0.00 | -400 | 52.7K | -0.8% | $0 | |
| M | 2023-11-08 | 2023-11-07 | REGN | RYAN ARTHUR F | Dir | S - Sale | $827.90 | -100 | 18.6K | -0.5% | -$82.8K |
| D | 2023-11-02 | 2023-11-01 | REGN | McCourt Marion | EVP Commercial | M - OptEx | $381.40 | +1,000 | 20.8K | +5% | +$381.4K |
| D | 2023-11-02 | 2023-11-01 | REGN | McCourt Marion | EVP Commercial | S - Sale+OE | $783.91 | -1,000 | 19.8K | -5% | -$783.9K |
| D | 2023-10-17 | 2023-10-13 | REGN | Zoghbi Huda Y | Dir | S - Sale+OE | $850.00 | -1,000 | 1,247 | -45% | -$850.0K |
| D | 2023-10-17 | 2023-10-13 | REGN | Zoghbi Huda Y | Dir | M - OptEx | $391.92 | +1,000 | 2,247 | +80% | +$391.9K |
| D | 2023-10-03 | 2023-10-02 | REGN | McCourt Marion | EVP Commercial | S - Sale+OE | $827.00 | -1,038 | 19.8K | -5% | -$858.4K |
| D | 2023-10-03 | 2023-10-02 | REGN | McCourt Marion | EVP Commercial | M - OptEx | $372.46 | +1,038 | 20.8K | +5% | +$386.6K |
| D | 2023-09-12 | 2023-09-08 | REGN | Schenkein David P | Dir | A - Grant | $0.00 | +240 | 240 | New | $0 |
| D | 2023-09-12 | 2023-09-08 | REGN | Guarini Kathryn | Dir | A - Grant | $0.00 | +240 | 240 | New | $0 |
| 2023-09-06 | 2023-09-01 | REGN | McCourt Marion | EVP Commercial | S - Sale | $834.55 | -250 | 19.8K | -1% | -$208.6K | |
| D | 2023-08-25 | 2023-08-23 | REGN | Fenimore Christopher R. | SVP Ctrl | M - OptEx | $399.66 | +7,000 | 26.1K | +37% | +$2.80M |
| D | 2023-08-25 | 2023-08-23 | REGN | Fenimore Christopher R. | SVP Ctrl | F - Tax | $842.66 | -5,198 | 20.9K | -20% | -$4.38M |
| DM | 2023-08-25 | 2023-08-24 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | S - Sale+OE | $841.71 | -6,197 | 27.6K | -18% | -$5.22M |
| D | 2023-08-25 | 2023-08-23 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | M - OptEx | $381.40 | +23.1K | 44.6K | +108% | +$8.82M |
| D | 2023-08-25 | 2023-08-23 | REGN | Van Plew Daniel P | EVP, General Mgr, Industrial | F - Tax | $842.66 | -16.9K | 27.7K | -38% | -$14.26M |
| 2023-08-25 | 2023-08-23 | REGN | Landry Robert E | EVP Fin CFO | S - Sale | $844.00 | -223 | 31.7K | -0.7% | -$188.2K | |
| DM | 2023-08-25 | 2023-08-23 | REGN | POON CHRISTINE A | Dir | S - Sale+OE | $839.97 | -12.3K | 8,987 | -58% | -$10.31M |
| D | 2023-08-25 | 2023-08-23 | REGN | POON CHRISTINE A | Dir | M - OptEx | $273.67 | +12.3K | 14.3K | +603% | +$3.36M |
| DM | 2023-08-23 | 2023-08-22 | REGN | STAHL NEIL | EVP Research, Development | S - Sale+OE | $840.98 | -11.7K | 58.5K | -17% | -$9.81M |
Purchase Sale Sale after option exercise All abbreviations